揚傑科技(300373.SZ)提示風險:在MOSFET和IGBT領域的未來發展存不確定性
格隆匯2月19日丨揚傑科技(300373.SZ)披露風險提示公告,公司與中芯集成電路製造(紹興)有限公司所籤協議僅為協議雙方根據合作意向達成的戰略性、框架性約定,協議所涉及的具體合作事宜需另行簽訂相關合作合同,預計協議不會對公司2020年度的財務狀況及經營成果構成重大影響。
另外,MOSFET和IGBT領域是公司近年來重點佈局的業務板塊,目前其銷售收入佔公司整體營業收入的比例相對較小。由於半導體行業市場化程度高,競爭激烈,公司在MOSFET和IGBT領域的未來發展存在不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.